SCHEMBL4003501

SCHEMBL4003501

Cc1cccc(NC(=O)CN2CCN(c3ccccc3F)CC2)c1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.75
TSHR P16473 5/20 0.75
DRD4 P21917 6/20 0.74
DRD2 P14416 2/20 0.74
DRD3 P35462 2/20 0.74
MAPK1 P28482 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
KMT2A Q03164 3/20 0.67
LMNA P02545 2/20 0.67
MAPT P10636 2/20 0.67
HTT P42858 1/20 0.67
NPSR1 Q6W5P4 1/20 0.66
CYP1A2 P05177 2/20 0.66
CYP3A4 P08684 2/20 0.66
CYP2C9 P11712 2/20 0.66
CYP2C19 P33261 2/20 0.66
GFER P55789 1/20 0.66
HSD17B10 Q99714 1/20 0.65
MEN1 O00255 1/20 0.65
GAA P10253 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4005427 0.88 DRD4 (0.78) ALDH1A1DRD4DRD2DRD3LMNA
SCHEMBL4002606 0.87 DRD4 (0.76) ALDH1A1DRD4DRD2DRD3KMT2A
SCHEMBL4004877 0.87 DRD4 (0.76) ALDH1A1DRD4DRD2DRD3KMT2A
SCHEMBL4008994 0.86 DRD4 (0.74) ALDH1A1DRD4DRD2DRD3KMT2A
SCHEMBL4004396 0.84 DRD4 (0.72) ALDH1A1DRD4DRD2DRD3KMT2A
SCHEMBL4010603 0.84 DRD4 (1.00) ALDH1A1DRD4DRD2DRD3CYP1A2
SCHEMBL4005507 0.84 DRD4 (1.00) ALDH1A1TSHRDRD4DRD2DRD3
SCHEMBL4009628 0.84 DRD4 (0.70) ALDH1A1DRD4DRD2DRD3SMN1; SMN2
SCHEMBL4010981 0.83 MEN1 (0.81) ALDH1A1DRD4DRD2DRD3SMN1; SMN2
SCHEMBL4004333 0.83 DRD4 (0.81) ALDH1A1TSHRDRD4DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509213-A2 ACETAMIDES AND BENZAMIDES THAT ARE USEFUL IN TREATING SEXUAL DYSFUNCTION Abbott Laboratories (US) 2005-03-02 EP claimed
US-20040029887-A1 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2004-02-12 US claimed
US-20030229094-A1 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2003-12-11 US claimed
WO-2003099266-A2 ACETAMIDES AND BENZAMIDES THAT ARE USEFUL IN TREATING SEXUAL DYSFUNCTION ABBOTT LABORATORIES (US) 2003-12-04 WO claimed
US-7528134-B2 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES INC. (US) 2009-05-05 US disclosed
US-20060009461-A1 Acetamides and benzamides that are useful in treating sexual dysfunction BHATIA PRAMILA A 2006-01-12 US disclosed
EP-1509213-A2 ACETAMIDES AND BENZAMIDES THAT ARE USEFUL IN TREATING SEXUAL DYSFUNCTION Abbott Laboratories (US) 2005-03-02 EP disclosed
US-20040029887-A1 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2004-02-12 US disclosed
US-20030229094-A1 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2003-12-11 US disclosed
WO-2003099266-A2 ACETAMIDES AND BENZAMIDES THAT ARE USEFUL IN TREATING SEXUAL DYSFUNCTION ABBOTT LABORATORIES (US) 2003-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229094-A1 Acetamides and benzamides that are useful in treating sexual dysfunction CATSPER1, CYP19A1, PDE12 ALDH1A1 88/4885TSHR 4192/4885DRD4 1497/4885
US-20040029887-A1 Acetamides and benzamides that are useful in treating sexual dysfunction CATSPER1, CYP19A1, PDE12 ALDH1A1 88/4885TSHR 4192/4885DRD4 1497/4885
US-20060009461-A1 Acetamides and benzamides that are useful in treating sexual dysfunction PDE12, NAAA, CYP19A1 ALDH1A1 193/4885TSHR 4010/4885DRD4 1334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.